In Utero Gene Therapy (IUGT) Using GLOBE Lentiviral Vector Phenotypically Corrects the Heterozygous Humanised Mouse Model and Its Progress Can Be Monitored Using MRI Techniques
Panicos Shangaris(St Thomas' Hospital), Anna L. David(University College Dublin), Paolo De Coppi(Great Ormond Street Hospital), Michael Antoniou(Guy's Hospital), Christina Flouri, Sindhu Subramaniam(University College London), Simon N. Waddington(University College London), Laurence H. Jackson(University College London), Thomas M. Ryan, Luca Urbani(King's College London), Shanrun Liu, Panagiotis Maghsoudlou(University of Bristol), Ayad Eddaoudi(University College London), Simon Eaton(Great Ormond Street Hospital), Joy Archer(University of Cambridge), Manfred Schmidt(Centre National de la Recherche Scientifique), Stavros Loukogeorgakis(Queen Mary University of London), Nahla Bakhamis(University College London), Michael P. Blundell(University College London), Wei Wang(Xihua University), Daniel J. Stuckey(University College London), Durrgah L. Ramachandra(University College London), Adrian J. Thrasher(Great Ormond Street Hospital)
Cited by 27
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite
|Hypertension|2008|1.1k
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
|New England Journal of Medicine|2002|1.1k